Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 GeneticVariation disease BEFREE Vanishing white matter (VWM) disease (OMIM#306896) is an autosomal recessive neurodegenerative leukodystrophy caused by hypomorphic mutations in any of the five genes encoding the subunits of eukaryotic translation initiation factor 2B (eIF2B). 31134486 2019
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 GeneticVariation disease BEFREE Vanishing white matter disease (VWM; MIM #603896), also known as childhood ataxia with central nervous system hypomyelination (CACH) syndrome, is an autosomal recessive transmitted leukoencephalopathy related to mutations in each of the 5 genes (EIF2B1, EIF2B2, EIF2B3, EIF2B4 and EIF2B5) encoding for the 5 subunits of eukaryotic translation initiation factor 2B (eIF2B), essential for protein synthesis. 16998732 2006
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 GeneticVariation disease BEFREE Vanishing white matter disease (VWM) is an autosomal recessive neurological disorder caused by mutation(s) in any subunit of eukaryotic translation initiation factor 2B (eIF2B), an activator of translation initiation factor eIF2. 31587290 2019
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 Biomarker disease BEFREE Vanishing white matter disease (VWM) is a progressive cavitating disease of central white matter due to a deficiency of the translation initiation factor eIF2B. 15217090 2004
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 GeneticVariation disease BEFREE Mutations in eIF2B have also recently been found to cause a fatal human disease called CACH (childhood ataxia with central nervous system hypomyelination) or VWM (vanishing white matter disease). 16246152 2005
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 GeneticVariation disease BEFREE A unique EIF2B mutation spectrum in Chinese VWM patients was shown. 19158808 2009
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 Biomarker disease BEFREE A yeast purification system for human translation initiation factors eIF2 and eIF2Bε and their use in the diagnosis of CACH/VWM disease. 23335982 2013
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 Biomarker disease BEFREE Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. 11835386 2002
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 GeneticVariation disease BEFREE In seven patients, we report for the first time mutations in three of the five EIF2B genes (EIF2B2, -4, and -5) that were recently shown to cause childhood ataxia with central nervous system hypomyelination/vanishing white-matter disease leukodystrophy. 12707859 2003
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 Biomarker disease BEFREE Further dissection of the signaling network associated with eIF2B function will help generating therapeutic strategies for VWM disease and possibly other neurodegenerative disorders. 28306143 2017
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 GeneticVariation disease BEFREE EIF2B1-5 genes encoding five subunits of eukaryotic translation initiation factor 2B (eIF2B) were analyzed in all patients with clinically suspected VWM disease. 31385086 2020
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 GeneticVariation disease BEFREE Mutations in each of the five eucaryotic initiation factor 2B (eIF2B) subunits have been found in leukodystrophies of various severity: Cree leukoencephalopathy, childhood ataxia with central hypomyelination/leukodystrophy with vanishing white matter and ovarioleukodystrophy. 15054402 2004
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 GeneticVariation disease BEFREE Vanishing white matter (VWM) disease is an autosomal genetic leukodystrophy caused by mutations in subunits of eukaryotic translation initiation factor 2B (eIF2B). 30279648 2018
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 GeneticVariation disease BEFREE The genes encoding all five subunits of eukaryotic translation initiation factor 2B (EIF2B) were analyzed in patients, who were tentatively diagnosed with VWM, by Sanger sequencing. 25843247 2015
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 GeneticVariation disease BEFREE Our findings imply CACH/VWM mutations do not specifically impair responses to eIF2 phosphorylation, but instead cause protein structure defects that impair eIF2B activity. 14993275 2004
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 GeneticVariation disease BEFREE Leukoencephalopathy with vanishing white matter (VWM), also called childhood ataxia with central nervous system hypomyelination (CACH), is an autosomal recessive disease caused by mutations in any of the five genes encoding subunits of the eukaryotic translation initiation factor eIF2B. 16823698 2006
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 GeneticVariation disease BEFREE The typical MRI pattern with a diffuse CSF-like aspect of the cerebral white matter can lack particularly in the adult forms whereas an increasing number of patients with clinical and MRI criteria for CACH/VWM disease but without eIF2B mutations are found. 20016818 2009
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 GeneticVariation disease BEFREE Vanishing white matter disease (VWM) is an inherited leukoencephalopathy in children attributed to mutations in EIF2B1-5, encoding five subunits of eukaryotic translation initiation factor 2B (eIF2B). 30720246 2019
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 GeneticVariation disease BEFREE Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. 11704758 2001
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 GeneticVariation disease BEFREE Efficient detection of frequent eIF2B mutations for the rapid molecular diagnosis of CACH/VWM syndrome. 26162493 2015
Childhood Ataxia with Central Nervous System Hypomyelinization
0.100 Biomarker disease BEFREE There is sufficient evidence suggesting role of eukaryotic translation initiation factor 2B (EIF2B) gene family encoding the five subunits of eIF2B complex-α, β, γ, δ and ε respectively, in causing vanishing white matter (VWM) disease of the brain. 28093708 2017
CUI: C1623038
Disease: Cirrhosis
Cirrhosis
0.010 GeneticVariation disease BEFREE Eukaryotic protein translation and recycling of eIF2:GDP related SNP variants were associated with ballooning, steatohepatitis and cirrhosis. 23894275 2013
CUI: C0009241
Disease: Cognition Disorders
Cognition Disorders
0.010 PosttranslationalModification group BEFREE ISRIB, a drug-like eIF2B activator, reverses the effects of eIF2 phosphorylation, and in rodents it enhances cognition and corrects cognitive deficits after brain injury. 29599213 2018
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.010 Biomarker disease BEFREE Bioinformatics analyses reveal that compared to control samples, the immunoproteomic IgG profiling of CRC samples is mainly associated with cell death, survival, and proliferation pathways, especially proteins involved in EIF2 and mTOR signaling. 29505855 2018
CUI: C4521042
Disease: Complete Trisomy 21 Syndrome
Complete Trisomy 21 Syndrome
0.010 Biomarker disease BEFREE Genetic and pharmacological suppression of the ISR, by inhibiting the ISR-inducing double-stranded RNA-activated protein kinase or boosting the function of the eukaryotic translation initiation factor eIF2-eIF2B complex, reversed the changes in translation and inhibitory synaptic transmission and rescued the synaptic plasticity and long-term memory deficits in DS mice. 31727829 2019